Bronchopulmonary Dysplasia and Impaired Neurodevelopment—What May Be the Missing Link?

Abstract

Bronchopulmonary dysplasia (BPD) and poor neurodevelopmental outcome after preterm birth are closely associated. However, mechanistic links are uncertain. We are exploring the hypothesis that decreased circulating insulin-like growth factor (IGF)-1 after preterm birth due to the abrupt end of supply by the placenta impairs growth during critical windows of development in most organs, including the lung and brain. Throughout gestation, the fetus uses glycolysis as its main source of energy. Metabolism is mainly stopped at pyruvate, which serves as a “metabolic crossroad”, allowing for the production of amino acids and other “building blocks” for new cells. Metabolic pathways are differentially regulated in the nucleus and the cytoplasm. The ratio between pyruvate dehydrogenase (PDH) and pyruvate dehydrogenase kinase (PDK) determines the biochemical activity which irreversibly metabolizes pyruvate to acetyl-co-A. Metabolites in the nucleus modulate epigenetic remodeling, an essential mechanism of normal growth and maturation during development. IGF-1 has been shown to contribute significantly to the development of virtually all organs, especially related to the regulation of microvascular growth, based on extensive studies of the brain, retina, lung, and intestine. With a preterm birth, the abrupt withdrawal of the placental supply of IGF-1 and its local production directly affects metabolism and microvascular development, which may contribute to a high risk for organ maldevelopment and injury after birth. We speculate that reduced bioavailability of IGF-1 is a possible link between lung and brain development disruption and increases susceptibility for major pulmonary and neurocognitive morbidities in preterm babies.

Key Points

• Metabolic changes inherent to prterm birth may cause epigenetic changes which cause “dysmaturational” development.

• IGF-1 may be the potential link between BPD and brain development.

• The ratio between pyruvate dehydrogenase and pyruvate dehydrogenase kinase determines the biochemical activity.

Keywords

development of the microvasculature - IGF1 expression - preterm birth

Publikationsverlauf

Eingereicht: 31. Juli 2022

Angenommen: 04. August 2022

Artikel online veröffentlicht:
01. November 2022

• References

• 1 Volpe JJ. Microglia: newly discovered complexity could lead to targeted therapy for neonatal white matter injury and dysmaturation. J Neonatal Perinatal Med 2019; 12 (03) 239-242
• 2 Volpe JJ. Dysmaturation of premature brain: importance, cellular mechanisms, and potential interventions. Pediatr Neurol 2019; 95: 42-66
• 3 Volpe JJ. Primary neuronal dysmaturation in preterm brain: important and likely modifiable. J Neonatal Perinatal Med 2021; 14 (01) 1-6
• 4 Bush A, Griese M, Seidl E, Kerem E, Reu S, Nicholson AG. Early onset children's interstitial lung diseases: discrete entities or manifestations of pulmonary dysmaturity?. Paediatr Respir Rev 2019; 30: 65-71
• 5 Sann L, Darre E, Lasne Y, Bourgeois J, Bethenod M. Effects of prematurity and dysmaturity on growth at age 5 years. J Pediatr 1986; 109 (04) 681-686
• 6 Awazu M. Structural and functional changes in the kidney caused by adverse fetal and neonatal environments. Mol Biol Rep 2022; 49 (03) 2335-2344
• 7 Fanni D, Gerosa C, Loddo C. et al. Stem/progenitor cells in fetuses and newborns: overview of immunohistochemical markers. Cell Regen (Lond) 2021; 10 (01) 22
• 8 Wolke D, Meyer R. Cognitive status, language attainment, and prereading skills of 6-year-old very preterm children and their peers: the Bavarian Longitudinal Study. Dev Med Child Neurol 1999; 41 (02) 94-109
• 9 Steiner P. Brain fuel utilization in the developing brain. Ann Nutr Metab 2019; 75 (Suppl 1): 8-18
• 10 Miyazawa H, Aulehla A. Revisiting the role of metabolism during development. Development 2018; 145 (19) dev131110
• 11 Jones CT. Fetal metabolism and fetal growth. J Reprod Fertil 1976; 47 (01) 189-201
• 12 Krisher RL, Prather RS. A role for the Warburg effect in preimplantation embryo development: metabolic modification to support rapid cell proliferation. Mol Reprod Dev 2012; 79 (05) 311-320
• 13 Senyilmaz D, Teleman AA. Chicken or the egg: Warburg effect and mitochondrial dysfunction. F1000Prime Rep 2015; 7: 41
• 14 Pascale RM, Calvisi DF, Simile MM, Feo CF, Feo F. The Warburg effect 97 years after its discovery. Cancers (Basel) 2020; 12 (10) E2819
• 15 Möllers LS, Yousuf EI, Hamatschek C. et al. Metabolic-endocrine disruption due to preterm birth impacts growth, body composition, and neonatal outcome. Pediatr Res 2022; 91 (06) 1350-1360
• 16 Saugstad OD, Kapadia V, Oei JL. Oxygen in the first minutes of life in very preterm infants. Neonatology 2021; 118 (02) 218-224
• 17 Li M, Santpere G, Kawasawa YI. et al; BrainSpan Consortium, PsychENCODE Consortium, PsychENCODE Developmental Subgroup. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 2018; 362 (6420): eaat7615
• 18 Hellström A, Ley D, Hansen-Pupp I. et al. Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants. Am J Perinatol 2016; 33 (11) 1067-1071
• 19 Holt RI, Simpson HL, Sönksen PH. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 2003; 20 (01) 3-15
• 20 Liegl R, Löfqvist C, Hellström A, Smith LE. IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum Dev 2016; 102: 13-19
• 21 Pais RS, Moreno-Barriuso N, Hernández-Porras I, López IP, De Las Rivas J, Pichel JG. Transcriptome analysis in prenatal IGF1-deficient mice identifies molecular pathways and target genes involved in distal lung differentiation. PLoS One 2013; 8 (12) e83028
• 22 Seedorf G, Kim C, Wallace B. et al. rhIGF-1/BP3 preserves lung growth and prevents pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Respir Crit Care Med 2020; 201 (09) 1120-1134